机构:[1]Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Stroke, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[2]Department of Radiology, Kaiser Permanente Medical Center, Los Angeles, USA[3]Department of Neurology, Neurovascular Imaging Research Core, UCLA, Los Angeles, California, USA[4]Department of Vascular Neurology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[5]Department of Neurology, Tiantan Clinical Trial and Research Center for Stroke, Beijing Tiantan Hospital, Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[6]Department of Neurology, Tiantan Clinical Trial and Research Center for Stroke, Beijing Tiantan Hospital, Capital Medical University, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[7]Department of Neurology, China National Clinical Research Center for Neurological Diseases, Tiantan Clinical Trialand Research Center for Stroke, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[8]Neuro-intensive Care Unit, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院[9]Department of Vascular Neurology, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Tiantan Clinical Trial and Research Center for Stroke, Center of Stroke, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China重点科室诊疗科室神经病学中心首都医科大学附属天坛医院
Objective To investigate the safety and efficacy of mechanical thrombectomy plus rescue therapy for intracranial large artery occlusion (ILAO) with underlying intracranial atherosclerosis (ICAS). Methods Patients enrolled in the intervention group of EAST (Endovascular Therapy for Acute ischemic Stroke Trial) were analyzed. For underlying ICAS identified during the stent retrieval procedure, rescue treatment was required for those with (1) a degree of arterial stenosis >70% or (2) any degree of arterial with blood flow impairment or (3) evidence of re-occlusion. Outcomes were compared between the ICAS group and the embolic group. Multivariate logistic regression was performed to determine independent predictors of functional independence at 90 days. Results Among the 140 patients included in the analysis, underlying ICAS was identified in 47 (34%), and 30 patients (21.4%) were considered to be eligible to receive rescue treatment. Of the 30 patients, 27 (90%) actually received rescue therapy. Recanalization rate (95.7% vs 96.8%, P=0.757) and functional independence at 90 days (63.8% vs 51.6%, P=0.169) were comparable between the ICAS group and the embolic group. No significant difference in symptomatic hemorrhage (4.3% vs 4.3%, P=1.000) or death (12.8% vs 12.9%, P=0.982) was found between the two groups. National Institutes of Health Stroke Scale score at presentation (OR=0.865, 95% CI 0.795 to 0.941; P=0.001) and modified Thrombolysis in Cerebral Infarction after the procedure (OR= 2.864, 95% CI 1.018 to 8.061; P=0.046) were independently associated with functional independence at 90 days. Conclusions Mechanical thrombectomy is safe in patients with ILAO with underlying ICAS. By employing a standard rescue therapy, favorable outcomes could be achieved in such patients.
基金:
National Science and Technology Major Project of China [2011BAI08B02, 2015BAI12B04, 2015BAI12B02]
第一作者机构:[1]Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Stroke, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
通讯作者:
通讯机构:[1]Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Center of Stroke, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China[*1]Beijing Tiantan Hospital, Capital Medical University, No.6, Tiantan Xili, Dongcheng district, Beijing 100050, China
推荐引用方式(GB/T 7714):
Jia BaiXue,Feng Lei,Liebeskind David S.,et al.Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis[J].JOURNAL OF NEUROINTERVENTIONAL SURGERY.2018,10(8):746-+.doi:10.1136/neurintsurg-2017-013489.
APA:
Jia, BaiXue,Feng, Lei,Liebeskind, David S.,Huo, Xiaochuan,Gao, Feng...&Miao, Zhong-Rong.(2018).Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis.JOURNAL OF NEUROINTERVENTIONAL SURGERY,10,(8)
MLA:
Jia, BaiXue,et al."Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis".JOURNAL OF NEUROINTERVENTIONAL SURGERY 10..8(2018):746-+